Efficacy of Electroacupuncture with different frequencies in the treatment of chemotherapy-induced peripheral neuropathy

Zhejiang Cancer Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Over 18 and under 70 years old, and the expected survival time was = 1 year; (2) Pathological diagnosis was malignant tumor, and peripheral neurotoxicity above grade 1 occurred after chemotherapy with platinum, paclitaxel and vinblastine; (3) Have daily living ability, no hearing loss, and can cooperate independently to complete all examinations; (4) No serious heart, liver, brain, kidney and other diseases, Karnofsky functional status score (KPS)>60; (5) Clear consciousness without mental illness or cognitive impairmen; (6) Signed the written informed consent form for the clinical trial.

•(1) Diagnoses of relatively severe systemic diseases (cardiovascular disease, acute infectious disease, haematopathy, endocrinopathy, allergy or methysis); (2) Diagnoses of depression, anxiety, schizophrenia orother severe mental disorders; (3) Diagnosed as peripheral neuropathy caused by other causes, such as peripheral nerve injury or diabetic peripheral neuropathy; (4) Pregnant and lactating women; (5) Alcohol and/or other drug abuse or dependen; (6) Participating in other clinical trials of acupuncture or drugs.

发起方